FTSE All-Share
|
4 954,11
|
-0,45
|
-0,01 %
|
Analysen zu FTSE All-Share-Werten
| 30.07.25 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.07.25 | Glencore Buy | Jefferies & Company Inc. | |
| 30.07.25 | GSK Hold | Jefferies & Company Inc. | |
| 30.07.25 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 30.07.25 | Diageo Buy | Jefferies & Company Inc. | |
| 30.07.25 | Glencore Outperform | RBC Capital Markets | |
| 30.07.25 | HSBC Holdings Neutral | UBS AG | |
| 30.07.25 | GSK Neutral | UBS AG | |
| 30.07.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.07.25 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 30.07.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | Glencore Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 30.07.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.07.25 | HSBC Holdings Buy | Jefferies & Company Inc. | |
| 30.07.25 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 29.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 29.07.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.07.25 | Shell Outperform | RBC Capital Markets | |
| 29.07.25 | AstraZeneca Buy | UBS AG | |
| 29.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.07.25 | Diageo Outperform | Bernstein Research | |
| 28.07.25 | National Grid Buy | Jefferies & Company Inc. | |
| 28.07.25 | GSK Outperform | Bernstein Research | |
| 28.07.25 | AstraZeneca Outperform | Bernstein Research | |
| 28.07.25 | London Stock Exchange Buy | UBS AG | |
| 24.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.07.25 | Vodafone Group Underperform | Bernstein Research | |
| 24.07.25 | Vodafone Group Neutral | UBS AG | |
| 24.07.25 | Vodafone Group Underweight | JP Morgan Chase & Co. | |
| 23.07.25 | Rio Tinto Buy | Deutsche Bank AG | |
| 23.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.07.25 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 23.07.25 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 22.07.25 | London Stock Exchange Outperform | RBC Capital Markets | |
| 22.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.07.25 | National Grid Overweight | Barclays Capital | |
| 21.07.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 21.07.25 | BP Neutral | UBS AG | |
| 21.07.25 | BAT Buy | Deutsche Bank AG |
HOT STOCKS DER LETZTEN 3 TAGE
| AstraZeneca | 6 |
| GSK | 4 |
| HSBC Holdings | 4 |
| Glencore | 3 |
| Rio Tinto | 3 |
| Diageo | 2 |
| Vodafone Group | 1 |
| Shell | 1 |
| National Grid | 1 |
| London Stock Exchange | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.